CXCL12 and neoplasm: These pathways are exploited during tumorigenesis, especially in the metastatic process, where CXCR4-expressing tumor cells are chemotactically homed to organs with abundant levels of CXCL12—such as the liver, bone marrow, lungs and lymph nodes [2–4].